文献速递心境障碍

小胶质细胞及其LAG3检查点介导电休克刺激的抗抑郁与促神经发生效应

Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation.
PubMed 文献 · Mol Psychiatry · 2021-10-14

该研究在小鼠慢性不可预测应激(CUS)抑郁模型中,用集落刺激因子-1拮抗剂PLX5622清除小胶质细胞,发现清除小胶质细胞不影响基线行为或对CUS的易感性,但完全阻断电休克刺激(ECS)的抗抑郁与促神经发生效应。海马RNA-Seq显示ECS上调神经发生与多巴胺信号相关基因、下调免疫检查点基因尤其Lag3,且这些分子变化在清除小胶质细胞后消失;LAG3单克隆抗体急性或慢性全身给药可快速逆转CUS诱导的小胶质细胞改变、抑郁样症状与神经发生损害。

要点

  • 清除小胶质细胞不影响基线行为与CUS易感性,但完全阻断ECS的抗抑郁和促神经发生效应。
  • ECS上调海马神经发生与多巴胺信号基因、下调免疫检查点基因,Lag3是唯一显著改变的小胶质细胞转录本。
  • LAG3单克隆抗体急性或慢性全身给药可快速逆转CUS诱导的抑郁样症状与神经发生损害。

核心结论

  • 脑内小胶质细胞LAG3检查点是新型抗抑郁治疗的有希望靶点。

研究设计与样本

  • 研究采用小鼠慢性不可预测应激(CUS)抑郁模型,并用集落刺激因子-1拮抗剂PLX5622清除小胶质细胞。
  • 研究观察ECS对抑郁样行为与神经发生的影响,并行海马RNA-Seq、免疫组化及LAG3单克隆抗体给药实验。

主要发现

  • 清除小胶质细胞不改变基线行为指标或对CUS的反应性,但完全消除ECS对抑郁样行为与神经发生损害的治疗效应。
  • 与ECS同时使用小胶质细胞抑制剂米诺环素也减弱ECS的抗抑郁与促神经发生效应。
  • 海马RNA-Seq显示ECS显著增加神经发生与多巴胺信号相关基因表达,并降低多个免疫检查点基因表达,尤其Lag3是唯一被ECS显著改变的小胶质细胞转录本。
  • 上述分子变化在清除小胶质细胞的小鼠中均未发生。
  • 免疫组化显示ECS逆转CUS诱导的小胶质细胞形态改变与LAG3受体表达升高。

关键数值与推荐

  • 急性或慢性全身给予LAG3单克隆抗体可进入脑实质,并在BV2小胶质细胞培养中作为直接检查点阻断剂。
  • LAG3单克隆抗体快速逆转CUS诱导的小胶质细胞改变、抑郁样症状与神经发生损害。

临床怎么用

  • 小胶质细胞LAG3检查点可作为新型抗抑郁治疗的潜在靶点。
  • ECS的抗抑郁与促神经发生效应依赖小胶质细胞,临床联合小胶质细胞抑制剂时需考虑可能减弱疗效。

局限性

  • 研究基于小鼠CUS模型,结论向人类临床转化仍需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite evidence implicating microglia in the etiology and pathophysiology of major depression, there is paucity of information regarding the contribution of microglia-dependent molecular pathways to antidepressant procedures. In this study, we investigated the role of microglia in a mouse model of depression (chronic unpredictable stress-CUS) and its reversal by electroconvulsive stimulation (ECS), by examining the effects of microglia depletion with the colony stimulating factor-1 antagonist PLX5622. Microglia depletion did not change basal behavioral measures or the responsiveness to CUS, but it completely abrogated the therapeutic effects of ECS on depressive-like behavior and neurogenesis impairment. Treatment with the microglia inhibitor minocycline concurrently with ECS also diminished the antidepressant and pro-neurogenesis effects of ECS. Hippocampal RNA-Seq analysis revealed that ECS significantly increased the expression of genes related to neurogenesis and dopamine signaling, while reducing the expression of several immune checkpoint genes, particularly lymphocyte-activating gene-3 (Lag3), which was the only microglial transcript significantly altered by ECS. None of these molecular changes occurred in microglia-depleted mice. Immunohistochemical analyses showed that ECS reversed the CUS-induced changes in microglial morphology and elevation in microglial LAG3 receptor expression. Consistently, either acute or chronic systemic administration of a LAG3 monoclonal antibody, which readily penetrated into the brain parenchyma and was found to serve as a direct checkpoint blocker in BV2 microglia cultures, rapidly rescued the CUS-induced microglial alterations, depressive-like symptoms, and neurogenesis impairment. These findings suggest that brain microglial LAG3 represents a promising target for novel antidepressant therapeutics.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Rimmerman N, Verdiger H, Goldenberg H, et al. Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation. Mol Psychiatry. 2021. PMID: 34650207. doi:10.1038/s41380-021-01338-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。